The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.

A Penn team used gene editing to screen for harmful variants of a gene that causes severe hypertrophic cardiomyopathy.

Neurimmune's antibody targets the misfolded SOD1 protein that has been implicated in a subset of ALS cases.

Aussie scientists say that blocking the RCAN1 gene helps the body turn unhealthy white fat into calorie-burning brown fat.

UCLA scientists say they’re closer to understanding the genes involved in the overproduction of the neuron-damaging protein tau.

At ASH, Fate will present preclinical data on three off-the-shelf, cancer-fighting cell therapies made from stem cells.

Using a library of gRNA-target pairs, Wellcome Sanger Institute scientists have developed a tool to predict CRISPR editing errors.

MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.